Bioorthogonal dissociative rhenium(i) photosensitisers for controlled immunogenic cell death induction
Open Access
- 24 October 2023
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Chemical Science
- Vol. 14 (46) , 13508-13517
Abstract
Rhenium(i) complexes modified with a tetrazine carbamate group were designed as bioorthogonally dissociative photosensitisers for the controlled induction of immunogenic cell death (ICD) after treatment with trans-cyclooct-4-enol and light.Keywords
Funding Information
- Innovation and Technology Commission
This publication has 48 references indexed in Scilit:
- Click to Release: Instantaneous Doxorubicin Elimination upon Tetrazine LigationAngewandte Chemie, 2013
- Mitochondria-targeting cyclometalated iridium(III)–PEG complexes with tunable photodynamic activityBiomaterials, 2013
- Innate and adaptive immune cells in the tumor microenvironmentNature Immunology, 2013
- Design, functionalization strategies and biomedical applications of targeted biodegradable/biocompatible polymer-based nanocarriers for drug deliveryChemical Society Reviews, 2012
- Immunogenic cell death and DAMPs in cancer therapyNature Reviews Cancer, 2012
- Biomedical Applications of Tetrazine CycloadditionsAccounts of Chemical Research, 2011
- Improved Survival with Ipilimumab in Patients with Metastatic MelanomaNew England Journal of Medicine, 2010
- Lysosomes and autophagy in cell death controlNature Reviews Cancer, 2005
- Enzyme-Catalyzed Activation of Anticancer ProdrugsPharmacological Reviews, 2004
- Human T-lymphocyte cytotoxicity and proliferation directed by a single chimeric TCRζ /CD28 receptorNature Biotechnology, 2002